Posted in | News | Packaging

Breakthrough with Photoinitiators for Packaging Inks

With Irgacure 270, BASF made a technological breakthrough in the development of cationic photoinitiators for packaging inks. For the first time, Irgacure 270 now makes it possible to combine fast UV curing with very low emissions. This new product is very versatile, and its applications include both UV-curable printing inks and clear overprint varnishes.

Photoinitiators are substances that form free radicals when they are exposed to UV light, and these radicals initiate polymerization reactions. Irgacure 270 is a new high-molecular-weight sulfonium salt which fulfills the high standards that UV-curable inks for food packaging are required to meet. Extensive tests have shown that emissions and migration are both very low. A complete registration package has been put together.

Irgacure 270 is mainly employed in UV-curable applications that demand low-emissions. These include clear overprint varnishes, flexographic inks, screen inks and inkjet inks for printing food packaging made from a variety of substrates such as paperboard, plastics and metal.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BASF Corporation. (2019, February 09). Breakthrough with Photoinitiators for Packaging Inks. AZoM. Retrieved on April 25, 2024 from https://www.azom.com/news.aspx?newsID=27072.

  • MLA

    BASF Corporation. "Breakthrough with Photoinitiators for Packaging Inks". AZoM. 25 April 2024. <https://www.azom.com/news.aspx?newsID=27072>.

  • Chicago

    BASF Corporation. "Breakthrough with Photoinitiators for Packaging Inks". AZoM. https://www.azom.com/news.aspx?newsID=27072. (accessed April 25, 2024).

  • Harvard

    BASF Corporation. 2019. Breakthrough with Photoinitiators for Packaging Inks. AZoM, viewed 25 April 2024, https://www.azom.com/news.aspx?newsID=27072.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.